133 related articles for article (PubMed ID: 26710975)
21. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.
Brown AF; Sirohi D; Fukuoka J; Cagle PT; Policarpio-Nicolas M; Tacha D; Jagirdar J
Arch Pathol Lab Med; 2013 Sep; 137(9):1274-81. PubMed ID: 23289761
[TBL] [Abstract][Full Text] [Related]
22. Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma.
Johnson H; Cohen C; Fatima N; Duncan D; Siddiqui MT
Acta Cytol; 2012; 56(6):596-602. PubMed ID: 23207437
[TBL] [Abstract][Full Text] [Related]
23. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.
Noh S; Shim H
Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426
[TBL] [Abstract][Full Text] [Related]
24. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
[TBL] [Abstract][Full Text] [Related]
25. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Bishop JA; Sharma R; Illei PB
Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
[TBL] [Abstract][Full Text] [Related]
26. Polyclonal napsin A expression: a potential diagnostic pitfall in distinguishing primary from metastatic mucinous tumors in the lung.
Heymann JJ; Hoda RS; Scognamiglio T
Arch Pathol Lab Med; 2014 Aug; 138(8):1067-71. PubMed ID: 25076295
[TBL] [Abstract][Full Text] [Related]
27. High-grade non-small cell lung carcinoma: a comparative analysis of the phenotypic profile in small biopsies with the corresponding postoperative material.
Szade J; Majewska HI; Żaczek AJ; Biernat W
Pol J Pathol; 2019; 70(2):100-108. PubMed ID: 31556560
[TBL] [Abstract][Full Text] [Related]
28. The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis.
Li L; Li X; Yin J; Song X; Chen X; Feng J; Gao H; Liu L; Wei S
PLoS One; 2014; 9(7):e100837. PubMed ID: 25003505
[TBL] [Abstract][Full Text] [Related]
29. Surfactant Protein A and Napsin A in the Immunohistochemical Characterization of Canine Pulmonary Carcinomas: Comparison With Thyroid Transcription Factor-1.
Beck J; Miller MA; Frank C; DuSold D; Ramos-Vara JA
Vet Pathol; 2017 Sep; 54(5):767-774. PubMed ID: 28578631
[TBL] [Abstract][Full Text] [Related]
30. Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.
Sethi S; Geng L; Shidham VB; Archuletta P; Bandyophadhyay S; Feng J; Madan S; Shi D; Tranchida P; Giorgadze T
Cytojournal; 2012; 9():10. PubMed ID: 22582081
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Aikawa E; Kawahara A; Hattori S; Yamaguchi T; Abe H; Taira T; Azuma K; Kage M
Cancer Cytopathol; 2011 Oct; 119(5):335-45. PubMed ID: 21717589
[TBL] [Abstract][Full Text] [Related]
32. Expression of squamous cell carcinoma markers and adenocarcinoma markers in primary pulmonary neuroendocrine carcinomas.
Masai K; Tsuta K; Kawago M; Tatsumori T; Kinno T; Taniyama T; Yoshida A; Asamura H; Tsuda H
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):292-7. PubMed ID: 23060301
[TBL] [Abstract][Full Text] [Related]
33. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.
Turner BM; Cagle PT; Sainz IM; Fukuoka J; Shen SS; Jagirdar J
Arch Pathol Lab Med; 2012 Feb; 136(2):163-71. PubMed ID: 22288963
[TBL] [Abstract][Full Text] [Related]
34. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma--sensitivity of TTF-1 is superior to napsin.
Terra SB; Aubry MC; Yi ES; Boland JM
Hum Pathol; 2014 Feb; 45(2):294-302. PubMed ID: 24331839
[TBL] [Abstract][Full Text] [Related]
36. The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia.
Piljić Burazer M; Mladinov S; Ćapkun V; Kuret S; Glavina Durdov M
Med Sci Monit; 2017 Jan; 23():489-497. PubMed ID: 28128193
[TBL] [Abstract][Full Text] [Related]
37. Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Chernock RD; El-Mofty SK; Becker N; Lewis JS
Am J Surg Pathol; 2013 Aug; 37(8):1215-22. PubMed ID: 23681073
[TBL] [Abstract][Full Text] [Related]
38. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
[TBL] [Abstract][Full Text] [Related]
39. The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
El-Maqsoud NM; Tawfiek ER; Abdelmeged A; Rahman MF; Moustafa AA
Tumour Biol; 2016 Mar; 37(3):3123-34. PubMed ID: 26427663
[TBL] [Abstract][Full Text] [Related]
40. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.
Terry J; Leung S; Laskin J; Leslie KO; Gown AM; Ionescu DN
Am J Surg Pathol; 2010 Dec; 34(12):1805-11. PubMed ID: 21107086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]